Navigation
Life Science Cluster für Hamburg und Schleswig-Holstein

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)
The Stentrode™ Endovascular Electrode Array (Photo: Synchron)

Synchron Acquires Equity Stake in ACQUANDAS

Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...

Read more …
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Prof. Thomas Feurer, Copyright: private
Prof. Thomas Feurer, Copyright: private

European XFEL: New Chairman of the Management Board

Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University ...

Read more …

The LSN year in snapshots

Dear Cluster stakeholders, dear LSN enthusiasts, we have searched through our photo archive and compiled a few highlights in pictures from the Life Science Nord ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …
Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)
Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)

Dr. Jürgen Walkenhorst is leaving Life Science Nord

Dr. Jürgen Walkenhorst has been LSN Managing Director since June 1st, 2022 and is leaving the cluster due to family reasons at the end of ...

Read more …
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (fr
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (from left to right) (Picture: Indivumed)

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...

Read more …

Minister Madsen visits European XFEL

Schleswig-Holstein's Minister of Economic Affairs, Transport, Employment, Technology and Tourism Claus Ruhe Madsen visited European XFEL yesterday. Mr Madsen familiarized himself with the fields of ...

Read more …
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)

#LifeScienceTour visits BioAgilytix

Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters ...

Read more …
Excellent atmosphere during the visit: Mayor Jan Lindenau, Minister of Economic Affairs Claus Ruhe Madsen and DEHAS Managing Director Jens Mittendorf exchanged ideas together with representatives of Life Science Nord and the Lübeck Economic Development Co
Excellent atmosphere during the visit: Mayor Jan Lindenau, Minister of Economic Affairs Claus Ruhe Madsen and DEHAS Managing Director Jens Mittendorf exchanged ideas together with representatives of Life Science Nord and the Lübeck Economic Development Corporation (from left).

A visit to DEHAS

Together with Schleswig-Holstein's Minister of Economic Affairs Claus Ruhe Madsen, Lübeck's Mayor Jan Lindenau and the Lübeck Economic Development Agency, we visited Life Science Nord ...

Read more …
Job board